Sankala Group
BTAL icon

Sankala Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Sankala Group’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$291K Buy
24,329
+7,118
+41% +$85.7K 0.19% 118
2026
Q2 		$209K Buy
17,211
+12,314
+251% +$150K 0.14% 140
2026
Q1 		$68.9K Buy
4,897
+3,157
+181% +$44.3K 0.06% 205
2025
Q4 		$24.5K Buy
+1,740
New +$26.2K 0.02% 295

Other funds holding BTAL

Carrera Capital Advisors
Carrera Capital Advisors Troy, Michigan $705M AUM 12.86% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Crescent Grove Advisors
Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
IFG Advisory
IFG Advisory Atlanta, Georgia $3.01B AUM 18.54% 1-Year Est. Return
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
PMV Capital Advisers
PMV Capital Advisers Dallas, Texas $80M AUM 20.89% 1-Year Est. Return
CFA
Collaborative Fund Advisors Reno, Nevada $186M AUM
Good Steward Wealth Advisors
Good Steward Wealth Advisors Clarksville, Tennessee $167M AUM 10.63% 1-Year Est. Return
Avestar Capital
Avestar Capital New York $1.27B AUM 25.49% 1-Year Est. Return

Sankala Group's BTAL Position: Q3 2026 in Review

Sankala Group increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 41% in Q3 2026, buying an estimated $85.7K and bringing the position to 24,329 shares worth $291K. The position accounts for 0.19% of the portfolio, ranked #118.

Sankala Group first reported a position in BTAL in Q4 2025 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold BTAL as of Q3 2026.

  • Sankala Group held 24,329 shares of AGF US Market Neutral Anti-Beta Fund worth $291K as of Q3 2026.
  • Sankala Group bought 7,118 AGF US Market Neutral Anti-Beta Fund shares in Q3 2026, an estimated $85.7K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.19% of Sankala Group's portfolio in Q3 2026, its #118 holding.
  • Sankala Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.